author-photo

Mamiko Sukeno

Kyoto Prefectural University of Medicine

8

Papers

47

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Novel RAF/MEK inhibitor CH5126766/VS-6766 has efficacy in combination with eribulin for the treatment of triple-negative breast cancer.

2021 Cancer Science
Show All
- Source
- Cite
- Save
Citations (0)
xCT Inhibition Increases Sensitivity to Vorinostat in a ROS-Dependent Manner.

2020 Cancers
Show All
- Source
- Cite
- Save
Citations (12)
Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma

2018 Cancer Letters
Show All
- Source
- Cite
- Save
Citations (11)
Blockage of the mevalonate pathway overcomes the apoptotic resistance to MEK inhibitors with suppressing the activation of Akt in cancer cells

2018 Oncotarget
Show All
- Source
- Cite
- Save
Citations (8)
The pleiotropic regulation of cyclin D1 by newly identified sesaminol-binding protein ANT2

2017
Show All
- Source
- Cite
- Save
Citations (13)